Anti-inflammation effect of Qingchang suppository in ulcerative colitis through JAK2/STAT3 signaling pathway in vitro and in vivo
Bibliographic Data
| ID | 14740871 |
|---|---|
| Authors | Tianyuan Yu (0000-0002-1849-5764, Longhua Hospital Shanghai University of Traditional Chinese Medicine), Zicheng Li (0000-0001-8533-5325, Pudong Medical Center), Liwei Xu (Suzhou Traditional Chinese Medicine Hospital), Ming Yang (0000-0002-6975-2548, Shanghai University of Traditional Chinese Medicine), Xin Zhou (0000-0003-2640-6431, Longhua Hospital Shanghai University of Traditional Chinese Medicine, corresponding author) |
| Year | 2021 |
| Volume | 266 |
| Pages | 113442 |
| Publication date | 2021-02-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ethnopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2020.113442 |
| PMID | 33027643 |
| OpenAlex | W3089511188 |
| Language | EN |
| Citations received | 4 |
| References cited | 33 |
Biology · Colitis · In vivo · Inflammation · Signal transduction · STAT protein · STAT3 · Traditional Chinese medicine · Ulcerative colitis · Cytokine Signaling Pathways and Interactions · Inflammatory Bowel Disease · Medicine · Pharmacological Effects of Natural Compounds · Biochemistry · Immunology · Internal Medicine · Pharmacology
Integrated network pharmacology and metabolomics analysis to reveal the potential mechanism of Ershen Wan in ameliorating ulcerative colitis
Qingchang suppository ameliorates mucosal inflammation in ulcerative colitis by inhibiting the differentiation and effector functions of Th1 and Th17 cells
Clinical efficacy and future application of indigo naturalis in the treatment of ulcerative colitis
Preventive effect of Atractylodis Rhizoma extract on DSS-induced acute ulcerative colitis through the regulation of the Mapk/NF-κB signals in vivo and in vitro
| Unique citing works | 4 |
|---|---|
| Citations per year | 1 |
| Citation span | 2022 - 2025 (4) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 4 |